Genes, Volume 16, Issue 10
2025 October - 123 articles
Cover Story: RNA-targeting techniques have emerged as powerful tools in cancer research, offering precise and programmable control over gene expression. Once considered passive messengers, RNA molecules are now recognized as critical regulators of cellular function, involved in oncogenesis, drug resistance, and tumor progression. This review offers a comparative analysis of key RNA-targeting strategies—including antisense oligonucleotides, RNA interference, CRISPR-Cas13, and RNA-binding molecules—focusing on their mechanisms, therapeutic potential, and limitations. We highlight their significant impact in precision oncology, recent FDA approvals, and ongoing clinical trials, underscoring their promise in next-generation cancer therapeutics. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.